Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer—II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin
- 1 June 1990
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 36 (1-2) , 105-109
- https://doi.org/10.1016/0022-4731(90)90119-d
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Megestrol acetate versus aminoglutethimide for metastatic breast cancerBreast Cancer Research and Treatment, 1989
- Oral High-Dose Progestins as Treatment for Advanced Breast CancerActa Oncologica, 1989
- Randomized Trial Comparing Aminoglutethimide With High-Dose Medroxyprogesterone Acetate in Therapy for Advanced Breast CarcinomauJNCI Journal of the National Cancer Institute, 1988
- Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: Relationship of response to previous treatmentEuropean Journal of Cancer and Clinical Oncology, 1986
- Oral high‐dose medroxyprogesterone acetate versus tamoxifen: A randomized crossover trial in postmenopausal patients with advanced breast cancerCancer, 1986
- Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patientsCancer Chemotherapy and Pharmacology, 1985
- The role of progestins and progesterone receptors in the treatment of breast cancerSteroids, 1984
- An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancerBritish Journal of Cancer, 1984
- Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effectsEuropean Journal of Cancer and Clinical Oncology, 1984
- Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancerPublished by Elsevier ,1979